Technical Analysis for NARI - Inari Medical, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Historical NARI trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Buy Signal | Bullish | 1.49% | |
| NR7 | Range Contraction | 1.49% | |
| Wide Bands | Range Expansion | 1.49% | |
| Oversold Stochastic | Weakness | 1.49% | |
| 50 DMA Resistance | Bearish | -1.24% | |
| Inside Day | Range Contraction | -1.24% | |
| Oversold Stochastic | Weakness | -1.24% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Rose Above Previous Day's High | 2 days ago | |
| Outside Day | 2 days ago | |
| Up 2% | 2 days ago | |
| Down 1% | 2 days ago | |
| Up 1% | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/11/2020
- Sector: Healthcare
- Industry: Medical Devices
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases.
Inari is focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.
Medicine Disease Catheter FDA Hematology Blood Clots Deep Vein Thrombosis Thrombosis Angiology Embolectomy Pulmonary Embolism Venous Thromboembolism
Medicine Disease Catheter FDA Hematology Blood Clots Deep Vein Thrombosis Thrombosis Angiology Embolectomy Pulmonary Embolism Venous Thromboembolism
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 84.9052 |
| 52 Week Low | 39.55 |
| Average Volume | 298,958 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 67.16 |
| 20-Day Moving Average | 71.84 |
| 10-Day Moving Average | 68.74 |
| Average True Range | 4.49 |
| ADX | 22.92 |
| +DI | 15.79 |
| -DI | 22.10 |
| Chandelier Exit (Long, 3 ATRs ) | 71.42 |
| Chandelier Exit (Short, 3 ATRs ) | 75.98 |
| Upper Bollinger Band | 83.28 |
| Lower Bollinger Band | 60.39 |
| Percent B (%b) | 0.18 |
| BandWidth | 31.86 |
| MACD Line | -1.07 |
| MACD Signal Line | 0.51 |
| MACD Histogram | -1.5838 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 69.16 | ||||
| Resistance 3 (R3) | 68.97 | 67.25 | 68.40 | ||
| Resistance 2 (R2) | 67.25 | 66.09 | 67.35 | 68.15 | |
| Resistance 1 (R1) | 65.93 | 65.37 | 66.59 | 66.12 | 67.89 |
| Pivot Point | 64.21 | 64.21 | 64.55 | 64.31 | 64.21 |
| Support 1 (S1) | 62.89 | 63.05 | 63.55 | 63.08 | 61.31 |
| Support 2 (S2) | 61.17 | 62.33 | 61.27 | 61.05 | |
| Support 3 (S3) | 59.85 | 61.17 | 60.80 | ||
| Support 4 (S4) | 60.04 |
